12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 4,431,609 | $701,523,705 | -3% | 3.55% |
| 2. | Kynam Capital Derrick Tang | 2,022,098 | $320,098,113 | -1% | 18.92% |
| 3. | Citadel Investment Group Ken Griffin | 1,430,968 | $226,522,234 | -38% | 0.03% |
| 4. | Maverick Capital Lee Ainslie | 1,366,054 | $216,246,348 | +2% | 3.89% |
| 5. | Castle Hook Partners Josh Donfeld And David Rogers | 1,222,578 | $193,534,097 | +8% | 2.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | 420,000 | 2022-05-12 | Filing | ||
| $28.81 | 159,783 | 400,989 | 2022-05-12 | Filing | ||
| $28.09 | 41,026 | 241,026 | 2022-05-12 | Filing | ||
| $33.49 | 40,695 | Director | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | Director | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $142.82 | 197 | 9,704 | 2025-04-01 | Filing | ||
| $142.25 | 365 | 9,901 | 2025-04-01 | Filing | ||
| $141.13 | 1,528 | 10,266 | 2025-04-01 | Filing | ||
| $140.17 | 1,512 | 11,794 | 2025-04-01 | Filing | ||
| $139.33 | 398 | 13,306 | 2025-04-01 | Filing |
Institutional Investors' Holdings
News See All
Here’s What Lifted Natera (NTRA) in Q4 and 2024
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Natera, Inc. (NASDAQ:NTRA) Q4 2024 Earnings Call Transcript
Operator: Welcome everyone to Natera's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Joe DiMenna’s Stock Portfolio: Top 10 Stocks to Buy
Zweig-DiMenna Associates Inc. is a U.S.-based hedge fund with a legacy spanning four decades. Established in 1984 by Joseph A.
Natera (NTRA) Surged on Blowout Quarterly Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Here’s Why Natera (NTRA) Surged in Q4
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.
Billionaire Stanley Druckenmiller’s Top 10 Stock Picks
On November 6, billionaire Stanley Druckenmiller appeared in a podcast, In Good Company, hosted by Nicolai Tangen, CEO of Norges Bank Investment Management.
Strong Volume Growth Lifted Natera (NTRA) in Q3
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Billionaire Hedge Funds
